(Reuters) - June 6 - Takeda Pharmaceuticals North America Inc., a unit of Japanese drugmaker Takeda Pharmaceutical Co. Ltd. , said it will add a boxed warning to the label of its diabetes drug, Actos, to increase awareness of risk of congestive heart failure.
The request came from the U.S. Food and Drug Administration, the company said in a statement.
Read more at Reuters.com Government Filings News
The request came from the U.S. Food and Drug Administration, the company said in a statement.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment